Quick Answer
China SXT Pharmaceuticals, Inc. reported Gross Profit of $367.4 thousand for the year ending 2025.
- China SXT Pharmaceuticals, Inc. showed a decrease of -33.7% in Gross Profit from 2024 to 2025.
- This data is from China SXT Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), China SXT Pharmaceuticals, Inc.'s Gross Profit has declined by 84.1%.
- Historical annual values: Fiscal year 2025: $367.4 thousand | Fiscal year 2024: $554.0 thousand | Fiscal year 2023: $426.3 thousand | Fiscal year 2022: $1.25 million | Fiscal year 2021: $2.84 million | Fiscal year 2020: $2.70 million | Fiscal year 2019: $4.61 million | Fiscal year 2018: $3.40 million | Fiscal year 2017: $2.31 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: